Is Bellicum Pharmaceuticals, Inc. (BLCM) a Buy, Sell, or Hold?
NASDAQ : BLCM
Bellicum Pharmaceuticals, Inc. — Institutional Ownership
$0.07475 USD
-$0.01 (-6.62%)
- Volume
- 6.06K
- Average Volume
- 27.95K
- Market Capitalization
- $778.33K
- P/E Ratio
- -0.09
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $1.31
- Year Low
- $0.06
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.31
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2025-08-14 | Armistice Capital, LLC | 1.08M | 9.99% |
| 2023-05-05 | Baker Bros. Advisors LP | 2.2M | 19.99% |
| 2023-05-05 | Felix J. Baker | 2.2M | 19.99% |
| 2023-05-05 | Baker Bros. Advisors (GP) LLC | 2.2M | 19.99% |
| 2023-05-05 | Julian C. Baker | 2.2M | 19.99% |
| 2022-11-18 | Richard A. Fair | 691.64K | 7.40% |
| 2022-02-15 | Steven Boyd | 932.05K | 9.99% |
| 2022-02-15 | Armistice Capital, LLC | 932.05K | 9.99% |
| 2022-02-09 | The Vanguard Group - 23-1945930 | 430.08K | 5.12% |
| 2021-02-16 | Boxer Capital, LLC | 265.74K | 4.99% |
| 2021-02-16 | Steven Boyd | 440.74K | 8.00% |
| 2021-02-16 | Armistice Capital, LLC | 440.74K | 8.00% |
| 2021-02-10 | 13-3127734 | 26631.0 | 0.53% |
| 2021-02-10 | 26-0385758 | 26631.0 | 0.53% |
| 2021-01-11 | Ikarian Capital, LLC | 500K | 9.90% |
| 2021-01-11 | Chart Westcott | 500K | 9.90% |
| 2021-01-11 | Ikarian Healthcare Fund GP, L.P. | 403.04K | 8.00% |
| 2021-01-11 | Ikarian Healthcare Master Fund, L.P. | 403.04K | 8.00% |
| 2021-01-11 | Neil Shahrestani | 500K | 9.90% |
| 2020-02-14 | Steven Boyd | 1.75M | 3.40% |
| 2020-02-14 | Armistice Capital, LLC | 1.75M | 3.40% |
| 2020-02-14 | Armistice Capital Master Fund Ltd. | 1.75M | 3.40% |
| 2020-02-12 | 26-0385758 | 2.58M | 5.18% |
| 2020-02-12 | 13-3127734 | 2.58M | 5.18% |
| 2019-08-26 | Armistice Capital, LLC | 3.23M | 6.50% |
| 2019-08-26 | 10 | 5.13M | 9.99% |
| 2019-08-26 | 9.99%** | 5.13M | 9.99% |
| 2019-08-26 | 10 | 5.13M | 9.99% |
| 2019-08-22 | Felix J. Baker | 2.68M | 5.80% |
| 2019-08-22 | Baker Bros. Advisors LP | 2.68M | 5.80% |
| 2019-08-22 | Julian C. Baker | 2.68M | 5.80% |
| 2019-08-22 | Baker Bros. Advisors (GP) LLC | 2.68M | 5.80% |
| 2018-02-13 | Abigail P. Johnson | 2.63M | 7.91% |
| 2018-02-13 | Select Biotechnology Portfolio | 1.91M | 5.75% |
| 2018-02-13 | FMR LLC | 2.63M | 7.91% |
| 2017-04-11 | Julian C. Baker | 5.03M | 15.20% |
| 2017-04-11 | Felix J. Baker | 5.03M | 15.20% |
| 2017-04-11 | Baker Bros. Advisors (GP) LLC | 5.03M | 15.20% |
| 2017-04-11 | Baker Bros. Advisors LP | 5.03M | 15.20% |
| 2017-01-30 | (1) BlackRock, Inc. | 1.67M | 6.20% |
| 2016-01-26 | JPMorgan Chase & Co. | 1.82M | 6.80% |
| 2015-12-24 | Baker Bros. Advisors LP | 4.87M | 18.40% |
| 2015-12-24 | Julian C. Baker | 4.87M | 18.40% |
| 2015-12-24 | Baker Bros. Advisors (GP) LLC | 4.87M | 18.40% |
| 2015-12-24 | Felix J. Baker | 4.87M | 18.40% |
| 2015-01-12 | 13-4093645 | 4.28M | 16.30% |
BLCM Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2022-12-31 | $0.72 | 30.83M | $22.2M | $21.84M | -$ | $359.34K |
| 2021-12-31 | $1.49 | 11.5M | $17.14M | $46.16M | -$ | -$29.01M |
| 2020-12-31 | $3.53 | 5.76M | $20.33M | $35.5M | $1.17M | -$13.99M |
| 2019-12-31 | $12.90 | 4.68M | $60.43M | $91.03M | $38.04M | $7.44M |
| 2018-12-31 | $29.20 | 4.02M | $117.47M | $43.7M | $35.96M | $109.74M |
| 2017-12-31 | $84.10 | 3.17M | $266.72M | $38.84M | $35.11M | $262.99M |
| 2016-12-31 | $136.20 | 2.7M | $367.07M | $33.14M | $1.79M | $335.72M |
| 2015-12-31 | $202.70 | 2.63M | $534.05M | $70.24M | $131K | $463.94M |
| 2014-12-31 | $230.40 | 2.51M | $578.06M | $191.6M | -$ | $386.46M |
| 2013-12-31 | $238.80 | 982.78K | $234.69M | $11.17M | $800K | $224.32M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2023-09-30 | $0.33 | 30.9M | $10.2M | $5.91M | -$ | $4.29M |
| 2023-06-30 | $0.37 | 30.84M | $11.41M | $7.41M | -$ | $4M |
| 2023-03-31 | $0.33 | 30.83M | $10.18M | $15.4M | -$ | -$5.23M |
| 2022-12-31 | $0.72 | 30.83M | $22.2M | $21.84M | -$ | $360.39K |
| 2022-09-30 | $1.20 | 30.83M | $37M | $28.76M | -$ | $8.24M |
| 2022-06-30 | $1.19 | 30.83M | $36.69M | $33.17M | -$ | $3.52M |
| 2022-03-31 | $2.16 | 30.82M | $66.57M | $39.77M | -$ | $26.8M |
| 2021-12-31 | $1.49 | 15.71M | $23.41M | $46.16M | -$ | -$22.74M |
| 2021-09-30 | $2.92 | 10.11M | $29.52M | $19.27M | -$ | $10.25M |
| 2021-06-30 | $3.30 | 10.11M | $33.36M | $20.28M | $39000 | $13.12M |
| 2021-03-31 | $3.76 | 10.03M | $37.73M | $28.08M | $58000 | $9.71M |
| 2020-12-31 | $3.53 | 7.87M | $27.79M | $35.5M | $1.17M | -$6.53M |